Human insulin-like growth factor II (IGF-
Insulin-like growth factors I and II (IGF-I and IGF-II) are polypeptide mitogens that share structural homology with insulin and exhibit a similar spectrum of biologic activities (1) (2) (3) (4) . They are thought to be important in postnatal growth (5, 6) . Several observations also suggest that IGF-II may play a role in fetal growth and development (7) (8) (9) (10) . Expression of human IGF-II mRNA has been examined in various fetal and adult tissues, including tumors (11) (12) (13) . The cDNA sequences of IGF-I and IGF-II predict that both are synthesized as large precursor molecules that undergo extensive processing. Recently, we reported the expression of the IGF-II gene in human placenta and showed that there are changes in the relative abundance of IGF-II mRNA during gestation (14) . Four major transcripts of 6.0, 4.9, 3.2, and 2.2 kilobases (kb) were detected when hybridized with a human liver-derived IGF-II cDNA probe containing the coding region.
Here we describe the isolation and sequencing of IGF-II cDNA from a human placental library. ¶ The 5' untranslated region (5'-UTR) sequence of this cDNA differs completely from that reported for human adult liver (15) . It has considerable base sequence identity to the same region of IGF-II cDNA isolated from a rat liver cell line, BRL-3A (16) , and to a small partial sequence reported recently for IGF-II cDNA isolated from human hepatoma (17) . By using the 5'-UTR as probe we demonstrated that placenta expresses no IGF-II transcripts with adult liver-like 5'-UTR and three of the four defined placental IGF-II transcripts hybridize to the placental 5'-UTR probe. These results indicate that the IGF-II gene may undergo an alternative splicing process as both UTR sequences are contained within the single IGF-II gene (16, 17) . Alternatively, it may be a result of tissue-specific promoter utilization and could be of developmental significance or be related to tissue-specific expression. It is also of interest that placental IGF-II transcripts are expressed at a much higher level in diabetic pregnancies.
METHODS
Placentas were handled as described (14) . The cDNA library was prepared according to Gubler and Hoffman (18) . By using 10 .tg of poly(A)+ RNA from a term placenta of an overt diabetic (class B), 1 x 105 individual clones were obtained. Colony hybridization was performed by using a 32P-labeled IGF-II cDNA insert as described (14 (17) . The predicted polypeptide has 94% amino acid sequence identity with rat IGF-II (16) . The 5'-UTR of clone 52 is composed of 546 bases and the 3'-UTR of this clone contains 264 bases.
Comparison with the human IGF-II genomic sequence (16, 22) indicates that the 5'-UTR and the 3'-UTR are incomplete. A possible reason for this is high G + C content (>65%) in the 5'-UTR and a similar structural barrier in the 3'-UTR of the placental IGF-II mRNA. By comparing the sequence of clone 52 with IGF-II cDNA sequences isolated from adult liver cDNA libraries (23, 24) , it is apparent that the coding regions and the 3'-UTRs are identical, whereas the 5'-UTRs are completely different, except for 8 bases upstream from the initiation codon, ATG ( (Fig. lc) . The IGF-II cDNA sequence obtained from an adult human liver library matches the exon gene sequences of IGF-IIA (11, 22) in which the 5'-UTR is interrupted by at least three introns of 11, 1.5, and >6 kb in length (Fig. ic) . The IGF-II cDNA sequence obtained from the placental library matches the exon gene sequences of human IGF-IIB (16) in which the 5'-UTR is interrupted by at least one intron of 2.68 kb (Fig. ic) . Since only one IGF-II gene has been detected in the human genome (11), the 5' exon (exon -1) of IGF-IIB may be contained within the large intron (11 kb) that separates exon 1 from exon -1 of IGF-IIA.
RNA molecules transcribed from a single gene but containing heterogeneous 5'-UTRs have been reported for a few eukaryotic genes. These transcripts may arise by different mechanisms. One such mechanism is single promoter usage with alternative transcription initiation and/or alternative splicing (25) . Another possible mechanism is alternative promoter usage (26) (27) (28) (29) . Frunzio et al. (29) reported that the IGF-II gene of rat BRL-3A cells contains two distinct promoter regions that are transcribed with differing efficiency, resulting in the production of RNAs having different 5' noncoding exons. However, since the 5'-UTR sequences of the IGF-II cDNA derived from the human adult liver and placenta are not complete, the mechanism(s) responsible for the heterogenous 5'-UTRs of these two human IGF-II mRNAs is, at present, unresolved and needs to be established. It has been suggested that the human IGF-II gene also contains two distinct promoters (17) .
The nucleotide sequences of the IGF-II cDNA from placenta are identical to the suggested exons -1, 1, 2, and 3 of the IGF-IIB gene (Fig. ic) reported by Dull et al. (16) . Therefore, the suggested exon-intron assignments for this gene are confirmed. Only a minor difference exists in the IGF-II cDNA from placenta. This difference occurs in the base sequence from positions -168 to -159 where a stretch of 10 deoxyadenosine residues is present ( Fig. lb; underlined). In contrast, the IGF-IIB gene contains a stretch of only 8 deoxyadenosine residues in the same relative sequence positions. Since sequencing of the IGF-II cDNA from placenta has been performed twice in this particular area, using two different subcloned fragments, and autoradiograms clearly showed 10 distinct adenosine bands, sequencing errors are unlikely to be the reason for the discrepancy. This difference may be the result of a reverse transcription error that occurred during cDNA synthesis, although this kind of error is rare. However, if our cDNA sequence from positions -159 to -168 is correct, there is an in-frame termination codon (TAA), at position -444 upstream from the ATG initiation codon ( Fig. lb; boxed) instead of an in-frame TGA termination codon at position -279, as suggested by the genomic DNA sequence (16) . However, in both cases the methionine at position -24 is the first amino acid in the prepro-IGF-II molecule since no other ATG is in phase between Met-24 and the TAA termination codon. Furthermore, comparison of sequences of the human placental IGF-II cDNA to those of buffalo rat liver IGF-II cDNA (16) indicates 80%o identity in the amino acid sequences of the coding regions. However, no apparent base sequence identity exists in the 3'-UTRs. In contrast the 5'-UTRs have 85% identity, overall, in their base sequences, with many areas having >90% homology (highly conserved areas) and few areas having <70% identity (variable areas) (Fig. 2) . This high degree of sequence conservation in the IGF-II 5'-UTRs may imply possible evolutionary and/or functional significance.
We recently reported that adult human liver-derived IGF-II cDNA, consisting ofthe 5'-UTR and protein coding region specifically hybridized to four (6.0, 4.9, 3.2, and 2.2 kb) placental poly(A)+ RNAs (14) . These IGF-II transcripts were present at each stage of gestation and the 6.-kb RNA was always the most abundant relative to the other three RNAs. Since the 5'-UTR of the IGF-II cDNA isolated from Medical Sciences: Shen et al. (23) consisting of the sequence beginning 190 bases upstream from the initiation codon, ATG (Fig. 3, probe B) , and probe containing a portion of the 5'-UTR of the adult liver IGF-II cDNA. These cDNA fragments were used to probe poly(A) + RNA from human placentas of each gestational stage in RNA transfer blot hybridizations. Probe A specifically hybridized to three of the four previously detected placental IGF-II transcripts. The sizes of the hybridizing IGF-II RNAs were 6.0, 3.2, and 2.2 kb (Fig. 3a) . These three transcripts were present at each stage of gestation. Term placenta from gestational and overt diabetic pregnancies seemingly express relatively more of these three IGF-II RNAs than term placenta from normal pregnancy. These data are in agreement with our previous observations that indicated that the expression of IGF-II RNA was increased in term placenta of overt and gestational diabetic pregnan- cies relative to normal term placenta (14) . This previous determination was made by using the adult human liver IGF-II cDNA, consisting of the 5'-UTR and protein coding region, as probe. In contrast, when probe B was used in hybridization experiments with placental poly(A)+ RNA as target, no transcripts were detected. As a control, adult human liver-derived IGF-II cDNA, which consists of 5'-UTR and protein coding region (probe C), was used to probe placental poly(A) + RNA. As expected, probe C specifically hybridized to four IGF-II RNAs of 6.0, 4.9, 3.2, and 2.2 kb in size (Fig. 3c) . Therefore, analysis of the results of these hybridizations using probes A, B, and C lead to the conclusion that the four IGF-II transcripts detected in human placenta most probably contain the same base sequence in their coding regions as that represented in the adult human liver IGF-II cDNA protein coding region. Further, it is apparent that these four placental IGF-II transcripts probably do not contain the same base sequence in their 5'-UTRs as that in the 5'-UTR of adult human liver IGF-II cDNA. Proc. Natl. Acad. Sci. USA 85 (1988) ,.
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In review, the 6.0-, 3.2-, and 2.2-kb IGF-II RNAs of human placenta appear to contain the same base sequence as those determined in clone 52. In contrast, the 4.9-kb IGF-II RNA of human placenta appears to contain the same base sequence as that determined for the protein coding region in clone 52. This transcript, however, does not contain a 5'-UTR base sequence homologous to that in either the 5'-UTR of clone 52 or the 5'-UTR of adult liver cDNA, suggesting the presence of a third base sequence in the 5'-UTR of human IGF-II RNA. The functional significance of these different IGF-II RNA 5'-UTRs is not known. In comparison, adult human kidney expresses two IGF-II transcripts of 6.0 and 4.9 kb. The 4.9-kb transcript appears to be present in greater relative abundance than the 6.0-kb transcript (11) . This 4.9-kb IGF-II transcript is similar in size to the placental IGF-1I transcript that apparently contains a third unique, as yet unsequenced, 5'-UTR, while maintaining the presence of the same coding region present in placental and liver IGF-II transcripts. (28) and the myosin light chains (32) . The specific function(s) of the differing IGF-II RNA 5'-UTRs is yet to be elucidated.
Finally, it should be noted that the BRL-3A rat liver cell line, expressing IGF-II RNA containing a 5'-UTR sequence with extensive identity to our sequence (16) , was derived from adult rat liver. Following culture these cells exhibited a fetal pattern of RNA expression (33) . This might indicate that the IGF-II RNA containing human placental-homologous IGF-II 5'-UTR is a developmentally regulated transcript expressed in fetal tissues and some tumors (17 (36) , using the rat BRL-3A 5'-UTR with homology to that reported here, showed tissue-specific and developmental expression of human IGF-II RNAs possessing this sequence.
